Furthermore, CD44+/CD24+ melanoma cells have been shown to have greater tumor-forming potential in vivo than CD44+/CD24–, suggesting that the increased malignant potential might be attributable to CD24 expression [104]. This evidence concerns the gene CD24 and neoplasm.